Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Cytocybernetics Inc
- Proposal award date
- 2020-07-09
- Contract end date
- 2021-08-31
- UEI
- G69NH6PMLT75
- Solicitation number
- PA19-272
- Topic code
- NHLBI
Research abstract
Optical assays are a powerful tool in cellular electrophysiology. However, currently-available approaches have not
reached their full potential. The major limitation of existing optical systems is that they are unable to determine the
absolute voltage in the cell. Current commercial approaches report only qualitative relative changes in voltage, andamp;
there is no information on absolute resting potential, diastolic potential, or action potential amplitude. Prior research
attempts to develop absolute voltage reports have been unsuccessful. In addition, currently available voltage-
sensitive dyes (VSDs) offer a very limited experimental duration (typically andlt; 30 min) dyes due to: 1) high washout andamp;
internalization rates, which removes them from the electrically active cell membrane; 2) high photo-toxicity, which
reduces the possible exposure time for measurements; andamp; 3) acute dye toxicity, which limits membrane loading andamp;
illumination, resulting in small signals andamp; low signal to noise ratio.This proposal overcomes these 2 major obstacles to develop andamp; optimize our novel system which combines our
VSDs andamp; our unique andamp; robust optical andamp; analytical system which determines absolute membrane potential. Our
integrated quantitative Optical Electrophysiology (qOEP) system consists of our patented long lasting VSDs,
optimized experimental protocols, optical detection system, andamp; analytical software. Our VSDs, which operate in the
red/NIR spectral range, have reduced acute chemical andamp; photo-toxicity, increased sensitivity, andamp; slower washout/
internalization rate. This gives them the ability to be used in experiments up to 4 hours. This dramatic improvement
revolutionizes the types of experiment which can be performed. Specifically, slower internalization rate gives the
experimenter time to calibrate the VSD, so that the measured light intensity can be directly correlated with
transmembrane potential. The spectral properties andamp; stability of this new generation of VSDs has been combined
with advances in electronics andamp; circuitry that increase signal sensitivity andamp; allow for qOEP. Dye performance andamp; signal
processing are species andamp; organ/cell type-specific. These systems have high degrees of cellular heterogeneity andamp;
connective tissue relative to cultured cells. To develop a consistent system we will optimize our qOEP system
specifically for work with electrically syncytial preparations of induced pluripotent stem cell derived (IPSCD) cardiac
myocytes. The goal is to optimize a cell system (stem cell derived cardiac myocytes) andamp; the dyes to make an
integrated optical system that makes qOEP available to almost any lab. This transformation will be similar to the
way that the advent of molecular biology kits made complex molecular biological techniques accessible to all. The
long term commercial opportunity is in cardiac safety screening to determine the arrhythmogenic potential of new drug
candidates in stem cell derived cardiac myocytes. Our novel system has the potential to have significant impact in
both the financial andamp; human health aspects of drug development. Successful completion of Phase I will result in a
system consisting of sensors, dyes, illumination sources, andamp; software that can be used for beta testing in Phase II. In
Phase II we will develop software, support, packaging andamp; optimized hardware for a turn-key commercial system.Optical imaging of electrical activity in cells enables the monitoring of cellular electrical activity to be
observed without the use of cumbersome, difficult and potentially damaging mechanical electrodes.
However, current optical methods are hampered by the unstable and damaging nature of currently
available voltage sensitive dyes, and they do not give information on absolute membrane potential. This
project will deliver a simple to use quantitative optical electrophysiology (qOEP) system, with long lasting
dyes, a novel optical detector, and software to determine actual membrane potential (during an action
potential and at rest) optimized for human induced pluripotent stem cell derived cardiac myocytes, which
will result in affordable, stable, reproducible, reliable, high quality optical recordings suitable for
identifying electrical activity in cardiac myocytes.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
9 SBIR/STTR records share this UEI (2015–2025). Reported award amounts total $6,874,751. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards